Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021

Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021

Abstract Objective To examine the burden of benign prostatic hyperplasia (BPH) in the Middle East and North Africa (MENA) region from 1990 to 2021 by age and sociodemographic index (SDI). Methods Data were sourced from the Global Burden of Disease (GBD) 2021 database. We analysed the incidence, prev...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saeid Safiri, Fikrettin Şahin, Reza Aletaha, Mark J. M. Sullman, Reza Shekarriz-Foumani, Ali-Asghar Kolahi
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	BMC Public Health
Subjects:	Benign prostatic hyperplasia Middle East and North Africa Global Burden of Disease Prevalence Incidence
Online Access:	https://doi.org/10.1186/s12889-025-21735-2
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The burden of prostate cancer in the North Africa and Middle East Region from 1990 to 2021
by: Saeid Safiri, et al.
Published: (2025-01-01)

Analysis of the disease burden of benign prostatic hyperplasia in China, the United States and Germany at 1990 and 2019
by: LU Peiwen, et al.
Published: (2024-05-01)

Burden and trends of dietary iron deficiency in the Middle East and North Africa region, 1990–2021
by: Saeid Safiri, et al.
Published: (2025-01-01)

National trends of surgery for benign prostatic hyperplasia in Finland
by: Alisa Salmivalli, et al.
Published: (2024-04-01)

Benign prostatic hyperplasia and periodontitis
by: YANG Shisong, et al.
Published: (2024-03-01)

Epidemiology of urinary tract infections in the Middle East and North Africa, 1990–2021
by: Fatemeh Amiri, et al.
Published: (2025-02-01)

Botulinum toxin and benign prostatic hyperplasia
by: Lay Guat Ng
Published: (2018-01-01)

Burden of Benign Prostatic Hyperplasia (BPH) in Low- and Middle-Income Countries in Sub-Saharan Africa (SSA)
by: Ayun Cassell, et al.
Published: (2024-10-01)

DECOMPENSATED URINARY BLADDER DUE TO BENIGN PROSTATIC HYPERPLASIA (LITERATURE REVIEW)
by: O.O. Sherstyuk, et al.
Published: (2022-08-01)

The burden of viral skin diseases in the Middle East and North Africa region, 1990–2021
by: Fatemeh Amiri, et al.
Published: (2025-08-01)

THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA
by: V. N. Pavlov, et al.
Published: (2018-08-01)

Meta-analysis of Acupuncture Intervening Benign Prostatic Hyperplasia
by: Xueyuan Yang, et al.
Published: (2025-03-01)

Systematic Review and Meta-Analysis on the Effectiveness of Tranexamic Acid in Controlling Bleeding During Transurethral Benign Prostatic Hyperplasia Surgery
by: Taofiq Olayinka Mohammed, et al.
Published: (2024-12-01)

The effect of systemic hypertension on prostatic arterial hemodynamics in dogs with benign prostate hyperplasia
by: Çağatay ESİN
Published: (2024-11-01)

The research progress on multi-omics analysis biomarkers of benign prostatic hyperplasia
by: QIAN Xinhang, et al.
Published: (2024-02-01)

Prevalence of benign prostatic hyperplasia and prostrate cancer among suburban residents in Southern Nigeria
by: Ugochukwu Esomonu, et al.
Published: (2024-12-01)

Identification of an intestinal microbiota enterotypes in ageing man diagnosed with benign prostatic hyperplasia (BPH)
by: Weronika Ratajczak-Zacharko, et al.
Published: (2025-05-01)

OPTIMIZATION OF TREATMENT AND PROGNOSTIC APPROACHES TO BENIGN PROSTATIC HYPERPLASIA COMPLICATIONS
by: S. M. Pikalov, et al.
Published: (2020-11-01)

Prostatic Artery Embolization: An Alternative Treatment for Benign Prostatic Hyperplasia
by: James F. Pike, et al.
Published: (2021-06-01)

Laser technologies in surgery for benign prostate hyperplasia
by: S. A. Rakhimov, et al.
Published: (2024-03-01)

Possibilities of Therapeutic and Prophylactic Tactics in Management of Benign Prostatic Hyperplasia in Tuberculosis Patients
by: Z. R. Rashidov, et al.
Published: (2021-08-01)

Oral glucose-lowering drugs and long-term risk of benign prostatic hyperplasia
by: Stanislav N. Volkov, et al.
Published: (2024-01-01)

Negative impact of benign prostatic hyperplasia on fertility in dogs–a mini-review
by: Anna Domosławska-Wyderska, et al.
Published: (2025-05-01)

Outcomes of Prostatic Artery Embolization for Treating Benign Prostatic Hyperplasia Symptoms: A Prospective Single‐Center Study
by: Sina Delazar, et al.
Published: (2025-03-01)

Urinary dysfunction in patients with unsatisfactory results of surgical treatment of benign prostatic hyperplasia
by: S. Kh. Al-Shukri, et al.
Published: (2017-12-01)

Oxidative Stress in Benign Prostatic Hyperplasia: Mechanisms, Clinical Relevance and Therapeutic Perspectives
by: Aris Kaltsas, et al.
Published: (2025-02-01)

The role of the androgen receptor in prostate development and benign prostatic hyperplasia: A review
by: Renee E. Vickman, et al.
Published: (2020-07-01)

Relationship and potential mechanisms between gut microbiota and benign prostatic hyperplasia
by: WANG Congcong, et al.
Published: (2024-05-01)

Identification and Characterization of Differentially Expressed MicroRNAs in Benign Prostatic Hyperplasia
by: Lingmin Song, et al.
Published: (2025-04-01)

Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2020-06-01)

Prostatectomy outcomes for patients with benign prostatic hyperplasia and its associated factors in East and West Gojjam zones comprehensive specialized hospitals, Northwest Ethiopia
by: Abebe Dilie Afenigus, et al.
Published: (2024-12-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

Doppler Ultrasonography in the Diagnosis of Dogs With Benign Prostatic Hyperplasia and Investigation of the Efficacy of Finasteride in Treatment
by: Burcu Esin, et al.
Published: (2025-05-01)

Health technology assessment (HTA) of prostatic urethral lift (PUL) for the treatment of benign prostatic hyperplasia (BPH) in the Italian context
by: Agostino Fortunato, et al.
Published: (2025-07-01)

Correlation of American Urological Association Symptom Index Domains with Uroflowmetric Peak Flow in Thai Patients with Suspected Benign Prostatic Hyperplasia
by: Sidaporn Chayochaichana, et al.
Published: (2024-11-01)

Choice Of treatment method for symptomatic Bladder outlet obstruction in patients with benign prostatic hyperplasia after kidney transplantation
by: S. V. Popov, et al.
Published: (2023-07-01)

Assessment of novel biomarkers of renal dysfunction associated with lower urinary tract symptoms in men with benign prostatic hyperplasia
by: V. Yu. Startsev, et al.
Published: (2024-11-01)

The use of 5-alpha reductase inhibitors in the treatment of benign prostatic hyperplasia
by: Eric H. Kim, et al.
Published: (2018-01-01)

Effect of benign prostatic hyperplasia surgery on ejaculatory function
by: M. P. Dianov, et al.
Published: (2024-04-01)

Therapeutic targets for benign prostatic hyperplasia: proteome-wide Mendelian randomization and colocalization analysis
by: Haolin Teng, et al.
Published: (2025-12-01)